Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma

Journal of Surgical Research

Volumn 180, Issue 1, 2013, Pages 104-113

  Sokolov, Eugene ^a   Eheim, Ashley L ^a   Ahrens, William A ^a   Walling, Tracy L ^a   Swet, Jacob H ^a   McMillan, Matthew T ^a   Simo, Kerri A ^a   Thompson, Kyle J ^a   Sindram, David ^a   McKillop, Iain H ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Guanine nucleotide regulatory protein; Hepatocellular carcinoma; Liver; LPAR6; Lysophosphatidic acid; Motility; Proliferation

Indexed keywords

BETA,GAMMA METHYLENEADENOSINE TRIPHOSPHATE; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1-6; MESSENGER RNA; UNCLASSIFIED DRUG;

AGED; ARTICLE; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; LIVER NEOPLASMS; LYSOPHOSPHOLIPIDS; MALE; MIDDLE AGED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER;

EID: 84873709968     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.10.054     Document Type: Article

References (42)

1. J.J. Shaw, and S.A. Shah Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean? Expert Rev Gastroenterol Hepatol 5 2011 365
2. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: a global view Nat Rev Gastroenterol Hepatol 7 2010 448
3. I.H. McKillop, D.M. Moran, and X. Jin Molecular pathogenesis of hepatocellular carcinoma J Surg Res 136 2006 125
4. I.H. McKillop, and L.W. Schrum Role of alcohol in liver carcinogenesis Semin Liver Dis 29 2009 222
5. C.R. McCudden, M.D. Hains, and R.J. Kimple G-protein signaling: back to the future Cell Mol Life Sci 62 2005 551
6. D.M. Rosenbaum, S.G. Rasmussen, and B.K. Kobilka The structure and function of G-protein-coupled receptors Nature 459 2009 356
7. G.K. Michalopoulos Liver regeneration J Cell Physiol 213 2007 286
8. N. Fausto, J.S. Campbell, and K.J. Riehle Liver regeneration Hepatology 43 2006 S45
9. A.M. Diehl, S.Q. Yang, and D. Wolfgang Differential expression of guanine nucleotide-binding proteins enhances cAMP synthesis in regenerating rat liver J Clin Invest 89 1992 1706
10. T. Yagami, S. Kirita, and A. Matsushita Alterations in the stimulatory G protein of the rat liver after partial hepatectomy Biochim Biophys Acta 1222 1994 81
11. C.M. Schmidt, I.H. McKillop, and P.A. Cahill The role of cAMP-MAPK signalling in the regulation of human hepatocellular carcinoma growth in vitro Eur J Gastroenterol Hepatol 11 1999 1393
12. I.H. McKillop, Y. Wu, and P.A. Cahill Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi-proteins) in experimental hepatocellular carcinoma J Cell Physiol 175 1998 295
13. C.M. Schmidt, I.H. McKillop, and P.A. Cahill Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma Hepatology 26 1997 1189
14. I.N. Berdichevets, T.V. Tyazhelova, and Kh.R. Shimshilashvili Lysophosphatidic acid is a lipid mediator with wide range of biological activities. Biosynthetic pathways and mechanism of action Biochemistry (Mosc) 75 2010 1088
15. J.W. Choi, D.R. Herr, and K. Noguchi LPA receptors: subtypes and biological actions Annu Rev Pharmacol Toxicol 50 2010 157
16. M.E. Lin, D.R. Herr, and J. Chun Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance Prostaglandins Other Lipid Mediat 91 2010 130
17. V. Katritch, V. Cherezov, and R.C. Stevens Diversity and modularity of G protein-coupled receptor structures Trends Pharmacol Sci 33 2012 17
18. P. Tangkijvanich, A.C. Melton, and C. Santiskulvong Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration J Biomed Sci 10 2003 352
19. M. El-Batch, W. Ibrahim, and S. Said Effect of histidine on autotaxin activity in experimentally induced liver fibrosis J Biochem Mol Toxicol 25 2011 143
20. O. Murch, M. Collin, and C. Thiemermann Lysophosphatidic acid reduces the organ injury caused by endotoxemia - a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma Shock 27 2007 48
21. N. Watanabe, H. Ikeda, and K. Nakamura Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity Life Sci 81 2007 1009
22. N.J. Skill, R.E. Scott, and J. Wu Hepatocellular carcinoma associated lipid metabolism reprogramming J Surg Res 169 2011 51
23. S.Y. Park, K.J. Jeong, and N. Panupinthu Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression Oncogene 30 2011 1351
24. S.M. Pasternack, I. von Kugelgen, and K. Al Aboud G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth Nat Genet 40 2008 329
25. B.B. Knowles, C.C. Howe, and D.P. Aden Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen Science 209 1980 497
26. H. Nakabayashi, K. Taketa, and K. Miyano Growth of human hepatoma cell lines with differentiated functions in chemically defined medium Cancer Res 42 1982 3858
27. E. Sokolov, D.A. Iannitti, and L.W. Schrum Altered expression and function of regulator of G-protein signaling-17 (RGS17) in hepatocellular carcinoma Cell Signal 23 2011 1603
28. E. Brandon-Warner, T.L. Walling, and L.W. Schrum Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis Alcohol Clin Exp Res 36 2012 641
29. S. Padma, A.M. Smeltz, and P.M. Banks Altered aquaporin 9 expression and localization in human hepatocellular carcinoma HPB (Oxford) 11 2009 66
30. A. Mazzocca, F. Dituri, and L. Lupo Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts Hepatology 54 2011 920
31. Y. Obo, T. Yamada, and M. Furukawa Frequent mutations of lysophosphatidic acid receptor-1 gene in rat liver tumors Mutat Res 660 2009 47
32. K. Yanagida, K. Masago, and H. Nakanishi Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6 J Biol Chem 284 2009 17731
33. P. Kant, and M.A. Hull Excess body weight and obesity - the link with gastrointestinal and hepatobiliary cancer Nat Rev Gastroenterol Hepatol 8 2011 224
34. A.C. Magalhaes, H. Dunn, and S.S. Ferguson Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins Br J Pharmacol 165 2012 1717
35. S.S. Karnik, C. Gogonea, and S. Patil Activation of G-protein-coupled receptors: a common molecular mechanism Trends Endocrinol Metab 14 2003 431
36. T. Mutoh, R. Rivera, and J. Chun Insights into the pharmacological relevance of lysophospholipid receptors Br J Pharmacol 165 2012 829
37. Y.B. Liu, Y. Kharode, and P.V. Bodine LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4 J Cell Biochem 109 2010 794
38. D.L. Baker, P. Morrison, and B. Miller Plasma lysophosphatidic acid concentration and ovarian cancer JAMA 287 2002 3081
39. M. Amano, M. Nakayama, and K. Kaibuchi Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity Cytoskeleton 67 2010 545
40. C.C. Wong, C.M. Wong, and S.L. Au RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N'Rho move it Liver Int 30 2010 642
41. H. Herrema, D. Czajkowska, and D. Théard Rho kinase, myosin-II, and p42/44 MAPK control extracellular matrix-mediated apical bile canalicular lumen morphogenesis in HepG2 cells Mol Biol Cell 17 2006 3291
42. L. Vardouli, E. Vasilaki, and E. Papadimitriou A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases FEBS J 275 2008 4074